Blincyto 欧州連合 - ルーマニア語 - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - leucemia limfoblastică limfoblastică a celulelor precursoare - agenți antineoplazici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Thalidomide BMS (previously Thalidomide Celgene) 欧州連合 - ルーマニア語 - EMA (European Medicines Agency)

thalidomide bms (previously thalidomide celgene)

bristol-myers squibb pharma eeig - thalidomide - mielom multiplu - imunosupresoare - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

DEPAKINE ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

depakine

sanofi - acidum valproicum + saruri - sirop - 57,64mg/ml - antiepileptice derivati de acizi grasi

DEPAKINE CHRONO 300 mg ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

depakine chrono 300 mg

sanofi - acidum valproicum + saruri - compr. elib. prel. - 300mg - antiepileptice derivati de acizi grasi

DEPAKINE 200 mg ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

depakine 200 mg

sanofi - acidum valproicum + saruri - compr. gastrorez. - 200mg - antiepileptice derivati de acizi grasi

DEPAKINE CHRONO 500 mg ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

depakine chrono 500 mg

sanofi - acidum valproicum + saruri - compr. elib. prel. - 500mg - antiepileptice derivati de acizi grasi

VALEPIL 200 mg/5 ml ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

valepil 200 mg/5 ml

meduman sa - romania - acid valproicum + saruri - sirop - 200mg/5ml - antiepileptice derivati de acizi grasi

LISVY 60 micrograme/24 ore+13 micrograme/24 ore ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lisvy 60 micrograme/24 ore+13 micrograme/24 ore

gedeon richter plc. - combinatii (gestodenum+etinilestradiolum) - plasture transdermic - 60micrograme/24 ore+13micrograme/24 ore - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe

CONVULEX 150 mg ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

convulex 150 mg

lannacher heilmittel ges.m.b.h. - austria - acid valproicum + saruri - caps. moi gastrorez. - 150mg - antiepileptice derivati de acizi grasi

CONVULEX 300 mg ルーマニア - ルーマニア語 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

convulex 300 mg

lannacher heilmittel ges.m.b.h. - austria - acid valproicum + saruri - caps. moi gastrorez. - 300mg - antiepileptice derivati de acizi grasi